Injection for treating thrombus

A technology of injection and Danshen injection, applied in blood diseases, extracellular fluid diseases, cardiovascular system diseases, etc., can solve the problems of acute onset, slow curative effect, and fierce onset of thrombotic diseases, and achieve economic burden, pH Reasonable, non-toxic and side effects

Inactive Publication Date: 2017-03-22
威海恒基伟业信息科技发展有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the curative effect of traditional Chinese medicine treatment is generally slow, and the drug dosage is large, and the bioavailability is low.
Due to the characteristics of acute onset and ferocious onset of thrombotic diseases, general traditional Chinese medicine preparations cannot achieve rapid onset of effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] Taking one injection as the dosage unit, each injection for the treatment of thrombus contains:

[0023] Salvia Injection 2mL

[0024] Chymotrypsin 1mg

[0025] Staphylokinase 100,000 IU

[0026] Add 5 mL of 0.9% normal saline.

[0027] The above medicines are mixed and sealed, strictly sterilized, stored at 0-10°C, and the shelf life is 1.5 years.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An injection for treating thrombus is prepared from a radix salviae miltiorrhizae injection, chymotrypsin and staphylokinase, wherein every 5 mL of the injection contains 1.8-2.5 mL of radix salviae miltiorrhizae injection, 0.8-1.2 mg of chymotrypsin and 80, 000-150, 000 IU of staphylokinase. The injection is mainly used for treating thrombus and vascular occlusion of the heart, the brain and all body parts, is mainly applicable to symptoms including insufficient blood supply to heart and brain, myocardial infarction, cerebral infarction, pulmonary infarction, venous thrombosis, arterial thrombosis and femoral head necrosis, and is remarkable in clinical efficacy; the total effective rate reaches 89%, and the cure rate is 76.5%.

Description

technical field [0001] The invention belongs to the field of medicine preparation, and in particular relates to an injection preparation for treating thrombus. The injection preparation of the present invention is prepared from the medicine of the national medicine Zhunzi brand. Background technique [0002] Thrombosis is one of the diseases that seriously endanger human health, especially cerebral thrombosis is difficult to cure clinically, and it is very easy to relapse, and most patients have sequelae. Therefore antithrombotic and thrombus-dissolving medicines are the focus of research by medical scientists from all over the world. [0003] At present, there are various kinds of antithrombotic drugs clinically and on the market, including oral drugs and injections, such as Xinnaokang, which is produced by more than a dozen manufacturers. In the early clinical stage, streptokinase and urokinase were used as the main means of dissolving thrombus, but the initial dose of s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/49A61K9/08A61P7/02A61P9/10A61K36/537A61K38/48
CPCA61K36/537A61K9/0019A61K9/08A61K38/4826A61K38/49C12Y304/21001C12Y304/21068
Inventor 吕志
Owner 威海恒基伟业信息科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap